1
|
Stanley KE: Lung cancer and tobacco - a
global problem. Cancer Detect Prev. 9:83–89. 1986.PubMed/NCBI
|
2
|
Kadara H, Kabbout M and Wistuba II:
Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology.
17:50–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Harris CC: The epidemiology of different
histologic types of bronchogenic carcinoma. Cancer Chemother Rep.
4:59–61. 1973.
|
4
|
Allen SS: Cigarette smoking among women:
how can we help? Minn Med. 97:41–3. 2014.PubMed/NCBI
|
5
|
Stellman SD, Muscat JE, Hoffmann D and
Wynder EL: Impact of filter cigarette smoking on lung cancer
histology. Prev Med. 26:451–456. 1997. View Article : Google Scholar : PubMed/NCBI
|
6
|
Hecht SS: Lung carcinogenesis by tobacco
smoke. Int J Cancer. 131:2724–2732. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Wen J, Fu JH, Zhang W and Guo M: Lung
carcinoma signaling pathways activated by smoking. Chin J Cancer.
30:551–558. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Galluzzo P and Bocchetta M: Notch
signaling in lung cancer. Expert Rev Anticancer Ther. 11:533–540.
2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Donnem T, Andersen S, Al-Shibli K, Al-Saad
S, Busund LT and Bremnes RM: Prognostic impact of Notch ligands and
receptors in nonsmall cell lung cancer: Coexpression of Notch-1 and
vascular endothelial growth factor-A predicts poor survival.
Cancer. 116:5676–5685. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Jiang X, Zhou JH, Deng ZH, Qu XH, Jiang HY
and Liu Y: Expression and significance of Notch1, Jagged1 and VEGF
in human non-small cell lung cancer. Zhong Nan Da Xue Xue Bao Yi
Xue Ban. 32:1031–1036. 2007.(In Chinese). PubMed/NCBI
|
11
|
Huang J, Song H, Liu B, et al: Expression
of Notch-1 and its clinical significance in different histological
subtypes of human lung adenocarcinoma. J Exp Clin Cancer Res.
32:842013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Haruki N, Kawaguchi KS, Eichenberger S, et
al: Dominant-negative Notch3 receptor inhibits mitogen-activated
protein kinase pathway and the growth of human lung cancers. Cancer
Res. 65:3555–3561. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhou M, Jin WY, Fan ZW and Han RC:
Analysis of the expression of the Notch3 receptor protein in adult
lung cancer. Oncol Lett. 5:499–504. 2013.PubMed/NCBI
|
14
|
Ye YZ, Zhang ZH, Fan XY, et al: Notch3
overexpression associates with poor prognosis in human
non-small-cell lung cancer. Med Oncol. 30:5952013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Shepherd FA, Crowley J, Van Houtte P, et
al International Association for the Study of Lung Cancer
International Staging Committee and Participating Institutions: The
International Association for the Study of Lung Cancer lung cancer
staging project: proposals regarding the clinical staging of small
cell lung cancer in the forthcoming (seventh) edition of the tumor,
node, metastasis classification for lung cancer. J Thorac Oncol.
2:1067–1077. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Travis WD, Garg K, Franklin WA, et al:
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical
importance and research relevance of the 2004 World Health
Organization pathologic criteria. J Thorac Oncol. 1:S13–S19. 2006.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhang L, Cheng Z, Liu W and Wu K:
Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and
sputum of stable chronic obstructive pulmonary disease patients.
COPD. 10:459–465. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yin Y, Hou G, Li E, Wang Q and Kang J:
PPARγ agonists regulate tobacco smoke-induced Toll like receptor 4
expression in alveolar macrophages. Respir Res. 15:282014.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Strober W: Trypan blue exclusion test of
cell viability. Curr Protoc Immunol. Appendix 3: Appendix 3B. 2001.
View Article : Google Scholar
|
20
|
Au WW, Su D and Yuan J: Cigarette smoking
in China: Public health, science and policy. Rev Environ Health.
27:43–49. 2012.PubMed/NCBI
|
21
|
Tilley AE, Harvey BG, Heguy A, et al:
Down-regulation of the notch pathway in human airway epithelium in
association with smoking and chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 179:457–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zheng Q, Qin H, Zhang H, et al: Notch
signaling inhibits growth of the human lung adenocarcinoma cell
line A549. Oncol Rep. 17:847–852. 2007.PubMed/NCBI
|
23
|
Kluk MJ, Ashworth T, Wang H, et al:
Gauging NOTCH1 activation in cancer using immunohistochemistry.
PLoS One. 8:e673062013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wael H, Yoshida R, Kudoh S, Hasegawa K,
Niimori-Kita K and Ito T: Notch1 signaling controls cell
proliferation, apoptosis and differentiation in lung carcinoma.
Lung Cancer. 85:131–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Westhoff B, Colaluca IN, D'Ario G, et al:
Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci
USA. 106:22293–22298. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Foster JG, Wong SC and Sharp TV: The
hypoxic tumor microenvironment: driving the tumorigenesis of
non-small-cell lung cancer. Future Oncol. 10:2659–2674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Graves EE, Maity A and Le QT: The tumor
microenvironment in non-small-cell lung cancer. Semin Radiat Oncol.
20:156–163. 2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Maity A and Koumenis C: Location,
location, location - makes all the difference for hypoxia in lung
tumors. Clin Cancer Res. 16:4685–4687. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Chen Y, De Marco MA, Graziani I, et al:
Oxygen concentration determines the biological effects of NOTCH-1
signaling in adenocarcinoma of the lung. Cancer Res. 67:7954–7959.
2007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Eliasz S, Liang S, Chen Y, et al: Notch-1
stimulates survival of lung adenocarcinoma cells during hypoxia by
activating the IGF-1R pathway. Oncogene. 29:2488–2498. 2010.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Baumgart A, Seidl S, Vlachou P, et al:
ADAM17 regulates epidermal growth factor receptor expression
through the activation of Notch1 in non-small cell lung cancer.
Cancer Res. 70:5368–5378. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Guo J, He L, Yuan P, et al: ADAM10
overexpression in human non-small cell lung cancer correlates with
cell migration and invasion through the activation of the Notch1
signaling pathway. Oncol Rep. 28:1709–1718. 2012.PubMed/NCBI
|
33
|
Hsu YL, Wu CY, Hung JY, Lin YS, Huang MS
and Kuo PL: Galectin-1 promotes lung cancer tumor metastasis by
potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway.
Carcinogenesis. 34:1370–1381. 2013. View Article : Google Scholar : PubMed/NCBI
|
34
|
Zhang S, Long H, Yang YL, et al:
Inhibition of CK2α down-regulates Notch1 signaling in lung cancer
cells. J Cell Mol Med. 17:854–862. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Allen TD, Rodriguez EM, Jones KD and
Bishop JM: Activated Notch1 induces lung adenomas in mice and
cooperates with Myc in the generation of lung adenocarcinoma.
Cancer Res. 71:6010–6018. 2011. View Article : Google Scholar : PubMed/NCBI
|
36
|
Zhou H, Luo Y, Chen JH, et al: Knockdown
of TRB3 induces apoptosis in human lung adenocarcinoma cells
through regulation of Notch1 expression. Mol Med Rep. 8:47–52.
2013.PubMed/NCBI
|
37
|
Ji X, Wang Z, Geamanu A, Sarkar FH and
Gupta SV: Inhibition of cell growth and induction of apoptosis in
non-small cell lung cancer cells by delta-tocotrienol is associated
with notch-1 down-regulation. J Cell Biochem. 112:2773–2783. 2011.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Ji X, Wang Z, Geamanu A, Goja A, Sarkar FH
and Gupta SV: Delta-tocotrienol suppresses Notch-1 pathway by
upregulating miR-34a in nonsmall cell lung cancer cells. Int J
Cancer. 131:2668–2677. 2012. View Article : Google Scholar : PubMed/NCBI
|
39
|
Ji X, Wang Z, Sarkar FH and Gupta SV:
Delta-tocotrienol augments cisplatin-induced suppression of
non-small cell lung cancer cells via inhibition of the Notch-1
pathway. Anticancer Res. 32:2647–2655. 2012.PubMed/NCBI
|
40
|
Xie M, He CS, Wei SH and Zhang L: Notch-1
contributes to epidermal growth factor receptor tyrosine kinase
inhibitor acquired resistance in non-small cell lung cancer in
vitro and in vivo. Eur J Cancer. 49:3559–3572. 2013. View Article : Google Scholar : PubMed/NCBI
|
41
|
Xie M, Zhang L, He CS, et al: Activation
of Notch-1 enhances epithelial-mesenchymal transition in
gefitinib-acquired resistant lung cancer cells. J Cell Biochem.
113:1501–1513. 2012.PubMed/NCBI
|
42
|
Liu YP, Yang CJ, Huang MS, et al:
Cisplatin selects for multidrug-resistant CD133+ cells in lung
adenocarcinoma by activating Notch signaling. Cancer Res.
73:406–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
43
|
Yang Y, Yan X, Duan W, et al:
Pterostilbene exerts antitumor activity via the Notch1 signaling
pathway in human lung adenocarcinoma cells. PLoS One. 8:e626522013.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Liu J and Mao Z, Huang J, Xie S, Liu T and
Mao Z: Blocking the NOTCH pathway can inhibit the growth of
CD133-positive A549 cells and sensitize to chemotherapy. Biochem
Biophys Res Commun. 444:670–675. 2014. View Article : Google Scholar : PubMed/NCBI
|
45
|
Dang TP, Gazdar AF, Virmani AK, et al:
Chromosome 19 translocation, overexpression of Notch3 and human
lung cancer. J Natl Cancer Inst. 92:1355–1357. 2000. View Article : Google Scholar : PubMed/NCBI
|
46
|
Konishi J, Kawaguchi KS, Vo H, et al:
Gamma-secretase inhibitor prevents Notch3 activation and reduces
proliferation in human lung cancers. Cancer Res. 67:8051–8057.
2007. View Article : Google Scholar : PubMed/NCBI
|
47
|
Sullivan JP, Spinola M, Dodge M, et al:
Aldehyde dehydrogenase activity selects for lung adenocarcinoma
stem cells dependent on notch signaling. Cancer Res. 70:9937–9948.
2010. View Article : Google Scholar : PubMed/NCBI
|
48
|
Weiss W: Cigarette smoke as a carcinogen.
Am Rev Respir Dis. 108:364–366. 1973.PubMed/NCBI
|
49
|
Reif AE: Effect of cigarette smoking on
susceptibility to lung cancer. Oncology. 38:76–85. 1981. View Article : Google Scholar : PubMed/NCBI
|